Results 121 to 130 of about 100,610 (328)

Blepharospasm in GNAO1 Syndrome May Benefit From Botulinum Toxins

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Eleonora Minacapilli   +4 more
wiley   +1 more source

Applications of Artificial Intelligence in Neurological Voice Disorders

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Neurological voice disorders, such as Parkinson's disease, laryngeal dystonia, and stroke‐induced dysarthria, significantly impact speech production and communication. Traditional diagnostic methods rely on subjective assessment, whereas artificial intelligence (AI) offers objective, noninvasive, and scalable solutions for voice analysis. This
Dongren Yao   +2 more
wiley   +1 more source

Amantadine Can Treat Blepharospasm in Levodopa Peak‐Dose Dyskinesia

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Francisco de Assis Aquino Gondim   +4 more
wiley   +1 more source

Dorsal Genital Nerve Stimulation as an Adjunctive Therapy to Control Neurogenic Detrusor Overactivity After Spinal Cord Injury

open access: yesArtificial Organs, EarlyView.
People with spinal cord injury (SCI) experience bladder overactivity, which can cause incontinence. Dorsal genital nerve stimulation (DGNS) can suppress overactivity, providing a longer duration to reach a toilet. People with SCI trialed home‐based DGNS for 8 weeks. DGNS was effective in the laboratory, and participants found home‐based DGNS acceptable.
Sean Doherty   +4 more
wiley   +1 more source

Neurophysiological Effect of Transcutaneous Electrical Spinal Cord Stimulation in Chronic Complete Spinal Cord Injury

open access: yesArtificial Organs, EarlyView.
TESCS‐ABT induced neurophysiological changes in individuals with chronic complete SCI, however these did not consistently translate into functional improvements. These findings highlight the role of residual supraspinal connectivity and inform future research to optimise this neurotechnology for SCI rehabilitation and identify likely responders ...
E. L. McNicol   +6 more
wiley   +1 more source

Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins. [PDF]

open access: yes, 2020
Botulinum neurotoxin (BoNT) is one of the most acutely lethal toxins known to humans, and effective treatment for BoNT intoxication is urgently needed. Single-domain antibodies (VHH) have been examined as a countermeasure for BoNT because of their high ...
Jin, Rongsheng   +8 more
core  

Experimental Parkinsonism induced by tetanus toxin injected into basal ganglia

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Local inhibitory circuits and long‐range inhibitory projections within the interconnected basal ganglia nuclei are critical for control of voluntary movement and pathophysiology of different extrapyramidal movement disorders.
Patrik Meglić   +6 more
wiley   +1 more source

Botulinum toxin treatment of spasticity in diplegic cerebral palsy : a randomised, double-blind, placebo-controlled, dose-ranging study [PDF]

open access: yes
This study evaluated the efficacy and safety of three doses of botulinum toxin A (BTX-A; Dysport®) in 125 patients (mean age 5.2 years, SD 2; 54% male)with dynamic equinus spasticity during walking. Participants were randomized to receive Dysport (10,
Bakheit   +32 more
core   +1 more source

Kinetics of the Thermal Inactivation of Type E Clostridium botulinum Toxin [PDF]

open access: gold, 1967
J. J. Licciardello   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy